⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1461549 | 0.91 | — | — | |
| SCHEMBL1685764 | 0.81 | ALDH1A1 (0.37) | — | |
| SCHEMBL27706934 | 0.81 | — | — | |
| SCHEMBL3131276 | 0.80 | — | — | |
| SCHEMBL1269985 | 0.79 | ALDH1A1 (0.69) | — | |
| SCHEMBL2818804 | 0.79 | ALDH1A1 (0.69) | — | |
| SCHEMBL3040312 | 0.76 | ALDH1A1 (0.64) | — | |
| SCHEMBL2945318 | 0.76 | ALDH1A1 (0.64) | — | |
| SCHEMBL2943010 | 0.76 | ALDH1A1 (0.64) | — | |
| SCHEMBL5915749 | 0.76 | ALDH1A1 (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100292439-A1 | Use of Functionalized Onium Salts for Peptide Synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE` (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20100292439-A1 | Use of Functionalized Onium Salts for Peptide Synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE` (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20100292439-A1 | Use of Functionalized Onium Salts for Peptide Synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE` (FR) | 2010-11-18 | — | — | US | disclosed |
| WO-2008003836-A1 | USE OF FUNCTIONALIZED ONIUM SALTS FOR THE SYNTHESIS OF PEPTIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-01-10 | — | — | WO | disclosed |
| US-6022822-A | Organotin compound and catalyst for transesterification comprising the same | RYOJI NOYORI (JP) | 2000-02-08 | — | — | US | disclosed |
| EP-0572489-B1 | STARTING COMPOUNDS FOR PREPARING CALCITRIOL AND ITS DERIVATIVES, METHOD FOR PREPARING THESE STARTING COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THIS METHOD | JENAPHARM GMBH (DE) | 1996-09-04 | — | — | EP | disclosed |
| CN-1026112-C | Process of preparing hydroxyalkylxanthines and medicines containing them and uses thereof | HOECHST AG (DE) | 1994-10-05 | — | — | CN | disclosed |
| EP-0572489-A1 | STARTING COMPOUNDS FOR PREPARING CALCITRIOL AND ITS DERIVATIVES, METHOD FOR PREPARING THESE STARTING COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THIS METHOD. | JENAPHARM GMBH (DE) | 1993-12-08 | — | — | EP | disclosed |
| WO-1992014746-A1 | STARTING COMPOUNDS FOR PREPARING CALCITRIOL AND ITS DERIVATIVES, METHOD FOR PREPARING THESE STARTING COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THIS METHOD | JENAPHARM GMBH (DE) | 1992-09-03 | — | — | WO | disclosed |
| EP-0268585-B1 | TERTIARY HYDROXYALKYLXANTHINES, THEIR MANUFACTURING PROCESS, MEDICINES CONTAINING THEM AND USE THEREOF | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-05-30 | — | — | EP | disclosed |
| US-4833146-A | BRAINS, BLOOD DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-23 | — | — | US | disclosed |
| EP-0268585-A1 | TERTIARY HYDROXYALKYLXANTHINES, THEIR MANUFACTURING PROCESS, MEDICINES CONTAINING THEM AND USE THEREOF. | HOECHST AG (DE) | 1988-06-01 | — | — | EP | disclosed |
| WO-1987000523-A2 | TERTIARY HYDROXYALKYLXANTHINES, THEIR MANUFACTURING PROCESS, MEDICINES CONTAINING THEM AND USE THEREOF | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-01-29 | — | — | WO | disclosed |
| CN-86105835-A | Preparation method of tertiary hydroxyalkyl xanthines, medicine containing tertiary hydroxyalkyl xanthines and application thereof | — | 1987-01-14 | — | — | CN | disclosed |